Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Cash & Current Investments (2010 - 2026)

Incyte's (INCY) quarterly Cash & Current Investments came in at $4.5 billion in Q2 2026, up 87.29% YoY from $2.4 billion in Q2 2025, and up 12.95% on a QoQ basis from $4.0 billion in Q1 2026.

Analysis

Incyte (INCY) Cash & Current Investments (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Cash & Current Investments data on file, last reported at $4.5 billion in Q2 2026.

  • Quarterly Cash & Current Investments rose 87.29% year-over-year to $4.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.5 billion (up 87.29% YoY) and the FY2025 annual result came in at $3.6 billion, up 65.92% from the prior year.
  • Cash & Current Investments advanced to $4.5 billion in Q2 2026, from $4.0 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $4.5 billion in Q2 2026 to a low of $1.4 billion in Q2 2024.
  • A 5-year average of $3.0 billion and a median of $3.0 billion in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments tumbled 57.66% — and 2026, when it soared 87.29%.
  • Tracing INCY's Cash & Current Investments over 5 years: stood at $3.2 billion in 2022, then climbed by 12.88% to $3.7 billion in 2023, then plunged by 40.97% to $2.2 billion in 2024, then surged by 65.92% to $3.6 billion in 2025, then rose by 26.68% to $4.5 billion in 2026.
  • The last three Cash & Current Investments figures came in at $4.5 billion (Q2 2026), $4.0 billion (Q1 2026), and $3.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 4.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.54 Bn
Mar 31, 2026 4.02 Bn
Dec 31, 2025 3.58 Bn
Sep 30, 2025 2.93 Bn
Jun 30, 2025 2.42 Bn
Mar 31, 2025 2.41 Bn
Dec 31, 2024 2.16 Bn
Sep 30, 2024 1.77 Bn
Jun 30, 2024 1.45 Bn
Mar 31, 2024 3.85 Bn
Dec 31, 2023 3.66 Bn
Sep 30, 2023 3.52 Bn
Jun 30, 2023 3.42 Bn
Mar 31, 2023 3.11 Bn
Dec 31, 2022 3.24 Bn
Sep 30, 2022 2.98 Bn
Jun 30, 2022 2.72 Bn
Mar 31, 2022 2.54 Bn
Dec 31, 2021 2.35 Bn
Sep 30, 2021 2.28 Bn